What is Optovue?
Optovue is a key player in the development of intelligent diagnostic, screening, refraction, and finishing lab equipment specifically designed for eye care professionals. Their advanced product suite encompasses cutting-edge OCT systems, automated refraction devices, and sophisticated lens finishing equipment. By providing intuitive solutions, Optovue empowers opticians and optometrists to enhance patient care and optimize practice operations, serving a broad clientele including optical retailers, optometry practices, and ophthalmology clinics.
How much funding has Optovue raised?
Optovue has raised a total of $12.5M across 2 funding rounds:
Series B
$10.5M
Debt
$2M
Series B (2007): $10.5M with participation from iD SoftCapital Group, Acorn Campus, and Trevi Health Ventures
Debt (2021): $2M led by PPP
Key Investors in Optovue
iD SoftCapital Group
iD Ventures America is an investment firm that focuses on identifying and investing in North American companies characterized by visionary innovation and strong growth potential. The firm leverages its seasoned team's expertise in markets, manufacturing, and operations to provide valuable support to entrepreneurs.
Acorn Campus
Acorn Campus Ventures is a venture fund with incubation facility and infrastructure, if needed. Acorn focuses on the wireless, semiconductor, photonics, communications, internet and life science field.
Trevi Health Ventures
Trevi Health Capital is a specialist investment firm that provides healthcare-focused alternative asset management through private equity funds on a global scale. The investment team combines experienced investment professionals and senior-level executives and entrepreneurs with proven track records.
What's next for Optovue?
The recent major strategic investment signals a pivotal phase for Optovue, likely enabling accelerated product development, market expansion, and enhanced operational capabilities. This infusion of capital is expected to fuel further innovation in diagnostic and refractive technologies, solidifying Optovue's position as a leader in the ophthalmic equipment industry. The company is poised to leverage this strategic backing to deepen its market penetration and potentially explore new technological frontiers in vision science.
See full Optovue company page
